Moderna | The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants

DAILY UPDATE: Moderna Down with Mixed Markets

Posted on May 14, 2024 by Dr. David Edward Marcinko MBA MEd CMP™

MEDICAL EXECUTIVE-POST – TODAY’S NEWSLETTER BRIEFING

***

Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants

“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“

A Partner of the Institute of Medical Business Advisors , Inc.

http://www.MedicalBusinessAdvisors.com

SPONSORED BY: Marcinko & Associates, Inc.

***

http://www.MarcinkoAssociates.com

Daily Update Provided By Staff Reporters Since 2007.
How May We Serve You?

REFER A COLLEAGUE: MarcinkoAdvisors@msn.com

SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/

ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z

***

Here’s where the major benchmarks ended:

The S&P 500^® index (SPX) fell 1.26 points (0.02%) to 5,221.42; the Dow Jones Industrial Average lost 81.33 points (0.2%) to 39,431.51; the NASDAQ Composite^® ($COMP) gained 47.37 points (0.3%) to 16,388.24.
The 10-year Treasury note yield (TNX) dropped almost 2 basis points to 4.487%.
The CBOE Volatility Index^® (VIX) surged 1.05 to 13.60.

Biotechnology and food and beverage shares were among the market’s strongest sectors Monday, while communication services stocks were among the biggest laggards. Energy shares took pressure despite a jump of 1.2% in WTI Crude Oil (/CL) futures, which ended above $79 per barrel after slumping last week to two-month lows.

CITE: https://www.r2library.com/Resource

Moderna is “bleeding money” as its forthcoming RSV vaccine doesn’t appear to deliver better results than other RSV shots already on the market. (Bloomberg)

***

It’s ChatGPT-4o’s time to shine. The “o” stands for omni, and it’s the latest iteration of OpenAI’s signature chatbot. According to the company, it’s much faster with enhanced “capabilities across text, vision, and audio.”

CITE: https://tinyurl.com/2h47urt5

23% is the average portion of the bill hospitals collected from patients before treatment in Q1 of this year, up 3% YoY. (the Wall Street Journal)

CITE: https://tinyurl.com/tj8smmes

COMMENTS APPRECIATED

PLEASE SUBSCRIBE: MarcinkoAdvisors@msns.com

Thank You

***

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***

Filed under: "Ask-an-Advisor", Breaking News, Experts Invited, Financial Planning, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, iMBA, Inc., Information Technology, Investing, Marcinko Associates, Recommended Books, Sponsors, Touring with Marcinko | Tagged: Bloomberg, CBOE, ChatGPT, ChatGPT-4, crude oil, DJIA, energy, Marcinko, mixed stock markets, Moderna, NASDAQ, RSV, S&P 500, SPX, textbooks, TNX, VIX, WTI | Leave a comment »

Citigroup, Moderna and A.I. Referee

Posted on October 6, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

Citigroup announced a major reorganization aimed at eliminating unnecessary management layers. It will involve layoffs, but the bank didn’t say how many.

Bank Types: https://marcinkoassociates.com/bank-types/

One day after the CDC recommended that everyone above six months old get the new Covid booster, Moderna stock shot up. But it was mostly because the company showed it’s got a future beyond the virus with encouraging flu-shot trial results.

Elon Musk called for a regulator to ensure that AI development proceeds safely following a closed-door meeting with US lawmakers that also included Alphabet CEO Sundar Pichai and Meta’s Mark Zuckerberg—which was probably an awkward run-in for Musk.

***

COMMENTS APPRECIATED

Thank You

***

Filed under: "Ask-an-Advisor", Career Development, Financial Planning, Funding Basics, Glossary Terms, Information Technology, Investing | Tagged: banks, CitiGroup, covid, covid booster, elon musk, FB, Mark Zuckerberg, Moderna, musk, Sundar Pichai, Zuckerberg | Leave a comment »

DAILY UPDATE: FDA Approves COVID Booster while Sonders Speaks about the Markets

Posted on September 12, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

The U.S. Food and Drug Administration authorized and approved updated COVID boosters on Monday amid rising cases and hospitalizations across the country. The boosters made by Pfizer-BioNTech and Moderna, were formulated to target variants that are currently circulating, which are related to XBB – an offshoot of the omicron variant.

CITE: https://www.r2library.com/Resource

***

The US economy is in a “rolling recession” and a full-blown downturn looms, Liz Ann Sonders says.
Weakness in consumer goods and manufacturing is being offset by strength in services, she noted.
Charles Schwab’s chief investment strategist doesn’t expect a bunch of interest—rate cuts in 2024.

***

Here is where the major benchmarks ended:

The S&P 500 Index was up 29.97 points (0.7%) at 4,487.46; the Dow Jones Industrial Average (DJIA) was up 87.13 points (0.3%) at 34,663.72; the NASDAQ Composite was up 156.37 points (1.1%) at 13,917.89.
The 10-year Treasury note yield (TNX) was up about 3 basis points at 4.29%.
CBOE’s Volatility Index (VIX) was down 0.03 at 13.81.

The consumer discretionary sector, which includes stocks like Tesla and Amazon (AMZN), gained nearly 3% and ended at an eight-week high. Health care and utilities were also higher. Energy shares dropped as crude oil futures eased, but oil prices remained near 10-month highs.

***
COMMENTS APPRECIATED

Thank You

***

Filed under: "Ask-an-Advisor", Alerts Sign-Up, Drugs and Pharma, Ethics, Health Economics, Health Insurance, Health Law & Policy, iMBA, Inc., Investing | Tagged: AMZN, BioNTech, CBOE, covid, covid booster, DJIA, DOW, FDA, Food Drug Administration, Liz Ann Sonders, Moderna, NASDAQ, omicron, Pfizer, recession, rolling recession, Russell 2000, S&P 500, stock markets, TNX, VIX, XBB | Leave a comment »

COVID VACCINE NEWS: The Companies

Posted on August 22, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

Stocks started the week on an upswing as technology companies rallied—including Nvidia, whose earnings report investors eagerly await tomorrow—helping the NASDAQ snap a four-day losing streak.

But, a new Covid variants are helping to push up the value of companies that make vaccines. Novavax, Moderna, BioNTech, and Pfizer rose yesterday as fall is likely to bring demand for boosters.

CITE: https://www.r2library.com/Resource

And, Atlanta-based Morris Brown College has announced that the school is reinstating its Covid mask mandate for the next two weeks as a result of positive cases at the Atlanta University Center.

The historically black college posted a note on its official Instagram account noting that the protocols would be in effect for the next 14 days. This includes a requirement for mask-wearing by students and employees, physical distancing, contact tracing, and other significant efforts to reduce the spread of Covid-19 among the population on the Atlanta campus.

***

COMMENTS APPRECIATED

Thank You

***

Filed under: Breaking News, Drugs and Pharma, Ethics, Health Economics, Health Insurance, Investing, LifeStyle | Tagged: BioNTech, covid, covid mask, covid mask mandates, covid masks, covid vaccines, infections, Moderna, morris brown college, Novavax, Nvidia, Pfizer | Leave a comment »

DAILY UPDATE: “Office of Long COVID Research and Practice”, and the Markets

Posted on August 1, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

This week executives from Pfizer, Moderna, AmerisourceBergen, Cigna, and other health companies are set to update investors on their latest financials and product offerings.

***

Markets: Stocks ended the day in the green closing out a July where all three major indexes ticked up—the NASDAQ most of all. It was the S&P 500’s fifth-straight month of gains, giving the index its best streak since 2021.
Palantir became the latest company to get a big AI boost after one analyst dubbed it the “Messi of A.I.” because the software company is poised to become a major player.

***

The Biden administration just announced it is forming a new Office of Long COVID Research and Practice to study the condition and help those who have been diagnosed with it. The office, which will be under the Department of Health and Human Services, “is charged with on-going coordination of the whole-of-government response to the longer-term effects of COVID-19,” according to a news release.

***

ORDER: https://www.routledge.com/Comprehensive-Financial-Planning-Strategies-for-Doctors-and-Advisors-Best/Marcinko-Hetico/p/book/9781482240283

***

COMMENTS APPRECIATED

Thank You

***

Filed under: "Advisors Only", Alerts Sign-Up, Health Insurance, Information Technology, Investing | Tagged: AI, CBOE, Cigna, covid, DJIA, DOW, earnings, gas, Messi, Moderna, NASDAQ, Office of Long COVID Research and Practice, oil, Pfizer, S&P 500, VIX | Leave a comment »

DAILY UPDATE: About the Markets

Posted on April 4, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

Major U.S. stock indexes ended mixed, after the announcement of a surprise OPEC+ production cut sent crude oil prices to two-month highs and fueled inflation concerns that could keep the Federal Reserve in policy-tightening mode. This weekend, several OPEC+ members, including Saudi Arabia, announced production cuts totaling nearly 1.2 million barrels a day that are slated to start in May. In response, WTI crude futures soared above $80 a barrel. Word of the planned cuts also boosted expectations that the Fed could raise its benchmark interest rate again in May as the central bank extends efforts to tamp down inflation. The OPEC+ cuts “suggest more headline inflation pressure in the near-term,” says Jeffrey Kleintop, chief global investment strategist at Charles Schwab & Co. The potential for further waves of inflation will “keep central banks from declaring victory over excessive price gains,” he adds. “That’s another headwind for tech stocks and other ‘long duration’ equities that get more of their cash flow in the future than in the near term.”

CITE: https://www.r2library.com

The following is a round-up of today’s market activity:

The S&P 500^® Index was up 15.2 (0.4%) at 4124.51, the highest close since Feb. 15; the Dow Jones industrial average was up 327 (1.0%) at 33601.15; the NASDAQ Composite was down 32.45 (0.3%) at 12189.45.
The 10-year Treasury yield was down about 7 basis points at 3.417%.
CBOE’s Volatility Index was down 0.14 at 18.56.

Oil producers and other energy companies led gainers Monday. Health care stocks also outperformed. Consumer discretionary and real estate were among the laggards.

Among individual stocks, Tesla (TSLA) shares tumbled over 6% following reports the electric car-maker delivered just 423,000 vehicles in the first quarter. Analysts had expected 430,000, according to research firm FactSet.

Looking ahead, medical companies, especially vaccine makers, may be worth watching this week with the World Vaccine Congress taking place in Washington, D.C. Some well-known vaccine makers include Moderna (MRNA), Johnson & Johnson (JNJ), and GlaxoSmithKline (GSK). Late last month, Walgreens Boots Alliance (WBA) reported a steep year-over-year decline in demand for COVID-19 vaccinations.

The U.S. dollar index fell slightly, while gold futures climbed above $2,000 per ounce to post their highest close in over two years.

CITE: https://www.amazon.com/Dictionary-Health-Information-Technology-Security/dp/0826149952/ref=sr_1_5?ie=UTF8&s=books&qid=1254413315&sr=1-5

***

ORDER: https://www.routledge.com/Comprehensive-Financial-Planning-Strategies-for-Doctors-and-Advisors-Best/Marcinko-Hetico/p/book/9781482240283

***

COMMENTS APPRECIATED

Thank You

***

Filed under: "Ask-an-Advisor", Breaking News, Funding Basics, Glossary Terms, Investing, Portfolio Management | Tagged: CBOE, DJIA, DOW, FactSet, GSK, Moderna, NASDAQ, oil treasury yields, OPEC, S&P 500, stock markets, Tesla, Volatility Index, walgreens | Leave a comment »

DAILY UPDATE: Wood, Moderna and the Domestic Down Markets

Posted on March 23, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

Cathie Wood just revealed that her flagship fund ARK Invest lost over $2 billion last year. Her struggles sum up how rising interest rates are affecting markets, according to the CEO of JPMorgan Asset Management. “When the Federal Reserve hits the brakes, something goes through the windshield,” George Gatch said.
Cathie Wood’s Ark Invest also sold $13.5 million worth of Coinbase stock. The famed money manager now holds a 7% stake in the crypto exchange worth $837 million. Shares of Coinbase are up nearly 30% in the past five trading sessions as crypto prices rallied.

***

Moderna – which received about $10 billion in taxpayer money to produce its COVID-19 vaccine and has since earned billions more in profits selling it – was sued in early 2022 by Genevant Sciences and Arbutus Biopharma Corp., which accused Moderna of using technology they have patented in its vaccine. The two companies have asked a federal court in Delaware to award them damages for the infringement.

CITE: https://www.r2library.com/Resource/Title/0826102549

***

Alex Coffey, senior trading strategist at TD Ameritrade, said recent turmoil in the banking industry has effectively tightened credit conditions, possibly making further rate increases by the Fed unnecessary. Still, the Fed had to send a message that it’s not making an abrupt shift in its efforts to bring inflation down. The Fed has been in “cruise control” raising rates, “staying in the fast lane,” Alex says. “Now, it has turned off cruise and maybe changed lanes, but isn’t doing a quick move toward the off ramp. Today’s increase was not a ‘dovish’ hike, but also not the hawkish stance that was feared.”

“We’re near the end of the tightening cycle,” he adds. “But they have to do this slowly.”

The Fed commentary appeared to briefly soothe the market, causing the S&P 500^® Index to rise as much as 1% soon after the central bank’s announcement, but the benchmark changed direction in the last hour of trading. The reversal may have in part been in response to the ambiguity of Powell’s words, as well as continuing concern about a potential recession.

And so, the following is a round-up of today’s domestic market activity:

The S&P 500 Index was down 65.90 (1.7%) at 3936.97; the Dow Jones industrial average was down 530.49 (1.6%%) at 32,030.11; the NASDAQ Composite was down 190.15 (1.6%) at 11,669.96.
The 10-year Treasury yield was down about 17 basis points at 3.44%.
CBOE’s Volatility Index was up 0.88 at 22.26.

ORDER: https://www.routledge.com/Comprehensive-Financial-Planning-Strategies-for-Doctors-and-Advisors-Best/Marcinko-Hetico/p/book/9781482240283

***

COMMENTS APPRECIATED

Thank You

***

Filed under: "Ask-an-Advisor", Alerts Sign-Up, Drugs and Pharma, Ethics, Experts Invited, Health Economics, Investing, Risk Management | Tagged: Alex Coffey, ARK, Asian stocks, CBOE, coinbase, crypto, DJIA, DOW, European stocks, Moderna, NASDAQ, S&P 500, TD Ameritrade, Volatility Index, Wood | Leave a comment »

DAILY UPDATE: Bird Flu Vaccine Up, FRB Down as Other Banks Rebound

Posted on March 21, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

Executives at GSK Plc (NYSE: GSK), Moderna Inc (NASDAQ: MRNA), and CSL Seqirus, owned by CSL (OTC: CSLLY), said they are developing or about to test sample human vaccines against bird flu as a precautionary measure against a future pandemic. Others, like Sanofi SA (NASDAQ: SNY), “stand ready” to begin production if needed, with existing H5N1 vaccine strains in stock. The U.N. said it had signed legally binding agreements with 14 manufacturers for 10% of their pandemic flu vaccine in a mix of donated doses and doses to be bought at affordable prices.

Health Insurance: https://www.amazon.com/Dictionary-Health-Insurance-Managed-Care/dp/0826149944/ref=sr_1_4?ie=UTF8&s=books&qid=1275315485&sr=1-4

***

Shares in troubled First Republic Bank crashed more than 46% on Monday, after reports the San Francisco-based bank may need to raise more funds despite a $30bn (£24bn) rescue last week.

***

U.S. stocks ended the day higher, as the financials sector bounced back amid the recent choppiness in the markets. Meanwhile, uncertainty remained regarding whether the turmoil will impact the Fed’s monetary policy decision on Wednesday. Banking stocks continued to be in focus, as UBS Group agreed to acquire Credit Suisse for a little over $3.0 billion, while the Fed and five other major central banks took action to increase the availability of liquidity for the financial system.

Treasury yields were higher, and the U.S. dollar was lower, while crude oil and gold prices gained ground.

Asia finished broadly lower, and markets in Europe rose sharply, as investors around the world contend with the latest updates surrounding global banks.

***

ORDER: https://www.routledge.com/Comprehensive-Financial-Planning-Strategies-for-Doctors-and-Advisors-Best/Marcinko-Hetico/p/book/9781482240283

***

COMMENTS APPRECIATED

Thank You

***

Filed under: Alerts Sign-Up, Drugs and Pharma, Ethics, Health Insurance, Health Law & Policy, Healthcare Finance, Research & Development, Risk Management | Tagged: Asian stocks, bank stocks, banks, bird flu, bird flu vaccine, Credit Suisse, CSL, European stocks, First Republic Bank, FRB, GSK, H5N1, Moderna, Sanofi, Treasury yields, UBS, UN | Leave a comment »

DAILY UPDATE: Amazon Downsizes While the Markets Dive

Posted on January 19, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

Amazon just began laying off thousands of more employees as the online retailer and cloud computing giant continues the largest job cuts in its history just months after an initial round of 10,000 job cuts. The Seattle Times and multiple other outlets reported Amazon made the staff reductions in its human resources and stores division, as the company is expected to lay off about an added 8,000 employees. Doug Herrington, Amazon’s worldwide retail chief, said in a memo the company would begin to notify employees by email Wednesday, according to Bloomberg.

***

Investors processed a slew of mixed economic data, as retail sales fell more than expected, producer price inflation cooled, industrial production dropped more than anticipated, home builder sentiment unexpectedly improved, mortgage applications jumped, and business inventories rose as expected.

Meanwhile, in afternoon action the Fed released its Beige Book, showing little change in activity from its last report. News on the equity front was mixed, as United Airlines topped Q4 estimates, and an optimistic outlook from J.B. Hunt took some of the sting off its earnings miss, while Moderna announced upbeat results from a key trial of its RSV vaccine.

Treasury yields were lower, and the U.S. dollar was nearly unchanged, while crude oil prices lost steam throughout the day to finish lower, and gold traded to the downside.

Asia finished mostly higher, and European markets were mixed, after the Bank of Japan held its monetary policy steady and offered dovish commentary.

***

CITE: https://www.r2library.com/Resource/Title/0826102549

***

ORDER: https://www.routledge.com/Comprehensive-Financial-Planning-Strategies-for-Doctors-and-Advisors-Best/Marcinko-Hetico/p/book/9781482240283

***

COMMENTS APPRECIATED

Thank You

***

Filed under: Alerts Sign-Up, Financial Planning, Investing | Tagged: Amazon, Amazon downsizes, beige book, DJIA, Doug Herrington, J. B. Hunt, markets dive, Moderna, NASDAQ, S&P500, Seattle Times | Leave a comment »

UPDATE: Stock Market History, S&P Performance and COVID Vaccines for Kids

Posted on June 18, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

***

By Staff Reporters

***

***

Per history, Bank of America’s Global Investment Strategy chief investment officer, Michael Hartnett, pointed out that the average peak-to-trough bear-market decline is 37.3% over a span of 289 days. Matching that pattern would put the end of current pain on Oct. 19th, 2022. This happens to mark the 35th anniversary of Black Monday, as the stock-market crash of 1987 is widely known. And according to statistical averages, the S&P 500 will likely bottom at 3,000.

Despite rising slightly, the S&P just posted its worst week since March 2020. Even energy stocks, one of the lone bright spots in the market, have taken a beating during this higher interest-rate era

The FDA just authorized two Covid-19 vaccines, Pfizer and Moderna, for kids under five—a year and a half after vaccines were approved for adults 16+.

***

COMMENTS APPRECIATED

Thank You

***

Filed under: Alerts Sign-Up, Drugs and Pharma, Ethics, Health Economics, Investing, LifeStyle | Tagged: Moderna, pediatric covid vaccines, S&P, S&P performance, stock market, stock market history, vaccines kids | Leave a comment »

Update on COVID-19 Booster Shots

Posted on April 6, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

***

***

Update on COVID-19 booster shots

In case you missed it: If you or a loved one are 50 or older, or are moderately or severely immunocompromised, you can get an additional Pfizer or Moderna COVID-19 booster shot at no cost to you.

The CDC recommends an additional booster shot for certain individuals to increase protection from severe disease from COVID-19. People over the age of 50, or who are moderately or severely immunocompromised, can get an additional booster of Pfizer or Moderna 4 months after their last dose.

This is especially important for those 65 and older who are at higher risk from severe disease and most likely to benefit from getting an additional booster.

Learn More: Remember: Medicare covers the COVID-19 vaccine, including booster shots, at no cost to you. Find a COVID-19 vaccine location near you.

Sincerely
The Medicare Team

COMMENTS APPRECIATED

Thank You

MORE: https://www.medicare.gov/medicare-coronavirus?utm_campaign=20220406_cvd_prv_gal&utm_content=english&utm_medium=email&utm_source=govdelivery

***

Filed under: Breaking News, Drugs and Pharma, Glossary Terms | Tagged: booster shots, CDC, corona, covid, Covid-19, Health Insurance, medicare, Moderna, pandemic, Pfizer, vaccines | Leave a comment »

UPDATE: The Markets, Oil, CPI, Meta and Moderna Stock

Posted on February 16, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

Bull Market - Meaning, Indicators, Examples of Stocks/Crypto, How it Works?

***

MARKETS: The Dow jumped 422 points, or 1.2%. The S&P 500 surged 1.5% and the NASDAQ was 2.5% higher.

OIL: US oil futures tumbled 3.7% to just under $92 a barrel. That’s despite the fact that Russia stressed that major military exercises would continue.

CPI: The Producer Price Index rose 1% last month, marking a significant acceleration from December’s 0.2% jump.

Meta: As Varietyreports, the company has agreed to pay $90 million to settle a 2012 class action lawsuit accusing it of violating users’ privacy. Facebook allegedly overstepped its bounds in 2010 and 2011 by using tracking cookies that monitored browsing after users signed out despite promises to the contrary.

MODERNA: Moderna Inc (NASDAQ: MRNA) shares were down more than 40% since the start of the year and continues to trend lower. Vaccine stocks are facing selling pressure as the COVID-19 omicron variant fades, but Moderna investors have been expressing concerns about recent stock sales from CEO Stéphane Bancel, as well as the presumed deletion of his Twitter account.

CITE: https://www.r2library.com/Resource/Title/082610254

***

COMMENTS APPRECIATED

Thank You

Subscribe to the Medical Executive-Post

***

Filed under: Alerts Sign-Up, Alternative Investments, Drugs and Pharma, Glossary Terms, Health Economics, iMBA, Inc., Investing | Tagged: bull market, DJIA, Facebook, FB, Meta, Moderna, NASDAQ, oil, S&P, stock markets | Leave a comment »

PODCAST: The Markets, Social Media Scams and Employment

Posted on January 31, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

Markets: Stocks just finished a period of high volatility and biotech companies in particular are feeling unsteady. The sector is off to its worst start to a year since 2016 and Moderna is the worst performer in the S&P 500.

Social Media: More than 95,000 people lost a collective $770 million due to fraud on social media last year, a new FTC report found. That represents 25% of all reported losses to fraud in 2021 and a breathtaking 18x increase over social media scam losses in 2017. Driving the surge was bogus cryptocurrencies. In fact, investment-related scams were the most prevalent type of fraud on social media, accounting for 37% of all losses. Romance scams (24%) were No. 2, and online shopping scams (14%) won the bronze medal.

Employment: The January employment rate dropped, but with Omicron forcing so many Americans to call out sick last month, the data may be specious. Economists polled by Dow Jones are estimating the economy added 200,000 jobs last month.

CITE: https://www.r2library.com/Resource/Title/082610254

COMMENTS APPRECIATED

Thank You

Subscribe to the Medical Executive-Post

***

Filed under: Alerts Sign-Up, Ethics, Glossary Terms, Health Economics, Information Technology, Investing, LifeStyle, Portfolio Management, Risk Management | Tagged: economists, economy, employment, Investing, Moderna, NASDAQ, omicron, romance scams, social media, social media scams, stock markets | Leave a comment »

UPDATE: The Markets and Pandemic

Posted on January 22, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

Stock Markets: The S&P and NASDAQ suffered their worst week since the pandemic began, tumbling 5.7% and 7.55%, respectively. But Peloton bounced back after Thursday’s wipe-out when CEO John Foley assured employees that execs “feel good about right-sizing our production.”
MORE: https://www.msn.com/en-us/money/markets/jeremy-grantham-predicts-the-us-superbubble-will-pop-wiping-out-dollar35-trillion-in-stocks-and-housing-here-are-the-11-best-quotes-from-his-new-note/ar-AAT0fa2?li=BBnbfcL

Covid Pandemic: A third dose of either Moderna or Pfizer-BioNTech’s Covid vaccine provided significant protection against severe disease in the US, according to three real-world reports that dropped yesterday. One analysis showed that the boosters were 90% effective at preventing hospitalization.
MORE: https://www.msn.com/en-us/health/medical/us-studies-highlight-the-need-for-covid-boosters-to-fight-omicron/ar-AAT0Y90?li=BBnb7Kz

CITE: https://www.r2library.com/Resource/Title/082610254

***

****

COMMENTS APPRECIATED.

Thank You

Subscribe to the Medical Executive-Post

***

Filed under: Alerts Sign-Up, Ethics, Glossary Terms, Investing | Tagged: corona virus, John Foley, Moderna, NASDAQ, pandemic, Peloton, Pfizer, S&P 500 | Leave a comment »

UPDATE: Markets, Pandemic, Economy and the IRS

Posted on January 11, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

Stock Markets: Down more than 2% with its back against the wall, the NASDAQ staged a huge comeback yesterday afternoon to close in the green and snap a 4-day losing streak.
Pandemic: Moderna was the S&P 500’s top performer after its CEO said that a booster shot targeting Omicron would soon enter clinical trials. Pfizer also said its Omicron booster would be ready by March.
Economy: A growing number of finance experts are taking the over when it comes to the number of interest rate hikes this year. Goldman Sachs now predicts the Fed will raise rates four times in 2022 (more than previously forecast) and JPMorgan CEO Jamie Dimon said he’d be surprised if it were only four hikes.
IRS: Even though tax filing season is just around the corner (opening January 24th with an April 18th deadline), the typically joyful and charismatic IRS has a case of the blues. On Monday, the Treasury Department warned that the agency has had a rough year and taxpayers should expect delays as returns are processed. According to Treasury officials, budget cuts and pandemic-related staffing shortages have created a towering backlog at the agency, and a “frustrating season” is on the horizon. While the IRS typically enters filing season with about 1 million unaddressed returns, the number stood at around 8.6 million in mid-Nov. 2021.
CITE: https://www.r2library.com/Resource/Title/0826102549

COMMENTS APPRECIATED.

Thank You

Subscribe to the Medical Executive-Post

***

****

Filed under: Alerts Sign-Up, Breaking News, Glossary Terms, Health Economics, Healthcare Finance, LifeStyle, Taxation | Tagged: Dimon, IRS, JP Morgan, Moderna, NASDAQ, omicron, pandemic, S&P, tax, Treasury | Leave a comment »

Round-Up on MARKETS and MEDICINE: 2022

Posted on January 3, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

Stock Markets: The three major equity indexes begin 2022 near record highs after closing out their best 3-year performance since 1999. The top-performing S&P sectors: Energy, whose 48% annual gain was its best ever (thank you, soaring oil prices). Real estate was the second-best performing sector at 42%, while tech and financials both rose 33%. The biggest winner in the S&P was Devon Energy, which gained nearly 190%. Ford, Moderna, and nine others in the index more than doubled their stock price. Microsoft rose 51%, and Apple’s 34% gain has it sitting close to a $3 trillion market capitalization.

Covid Medicine: Omicron has caused a rapid explosion of Covid cases in the US—the 7-day rolling average of nearly 400,000 new cases on Saturday was more than double the number from one week before. With hospitalizations also ticking higher, officials are warning that health systems will be overloaded before the Omicron wave is expected to peak in mid-January. And, Dr. Anthony Fauci said yesterday that health officials are looking at adding a negative test requirement after five days of quarantine. Under existing guidance, you can emerge from isolation without showing a negative test.
CITE: https://www.r2library.com/Resource/Title/082610254

COMMENTS ARE APPRECIATED

Subscribe to the Medical Executive-Post

***

Filed under: Breaking News, Health Economics, Investing | Tagged: corona, covid, Fauci, Ford, Moderna, NASDAQ, omicron, S&P, stock markets | Leave a comment »

UPDATE: Markets and Medicine

Posted on December 17, 2021 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

The Federal Reserve announced that it will stop buying bonds about three months earlier than initially planned. The Fed now plans to trim its monthly Treasury and mortgage-backed security purchases by $30 billion a month starting next month. The new pace is expected to put an end to bond buying by March.

CITE: https://www.r2library.com/Resource/Title/0826102549

The Fed also announced that it would leave interest rates unchanged at near-zero percent. The announcement paves the way for three interest rate hikes by the end of 2022, which could weigh on tech and growth stocks.

UPDATE: https://www.msn.com/en-us/money/news/tech-takes-a-beating-as-central-banks-pull-back/vi-AARTp0n

Markets: Stocks reversed their post-Federal Reserve announcement rally with a stinker of a day—especially tech stocks. Semiconductor companies like AMD and Nvidia got particularly thwacked.
Covid: The CDC recommended adults use Moderna’s and Pfizer’s Covid vaccines over J&J’s due to the risk of developing rare but serious blood clots.

MORE: https://www.msn.com/en-us/money/markets/stocks-fall-as-investors-digest-feds-latest-move/vi-AARTm2C

***
COMMENTS APPRECIATED.

***

Thank You

***

Filed under: Breaking News, Glossary Terms, Investing | Tagged: AMD, bonds, covid, Federal Reserve, inflation, interest rates, Investing, IRS, markets, Moderna, stock market | Leave a comment »

The HISTORY of Messenger RNA

Posted on September 22, 2021 by Dr. David Edward Marcinko MBA MEd CMP™

A Tangled History of mRNA

Hundreds of scientists had worked on mRNA vaccines for decades before the coronavirus pandemic brought a breakthrough.

By Elie Dolgin

***

Messenger RNA Medicines | Translate Bio | mRNA Therapeutics

***

LINK: https://www.nature.com/articles/d41586-021-02483-w?utm_source=pocket-newtabBy

YOUR COMMENTS ARE APPRECIATED.

Thank You

****

Filed under: "Doctors Only", Ethics, Experts Invited, Quality Initiatives | Tagged: Covid and Moderna, Elie Dolgin, messenger RNA, Moderna, mRNA, NATURE, vaccines | Leave a comment »

How the Vaccines Work?

Posted on February 10, 2021 by Dr. David Edward Marcinko MBA MEd CMP™

PFIZER-BioNTech and MODERNA

By staff reporters

***

Filed under: Drugs and Pharma, iMBA, Inc. | Tagged: Bio-N-Tech, Moderna, pandemic, Pfizer | Leave a comment »

VACCINE COMPARISON: Pfizer-BioNet V. Moderna

Posted on December 22, 2020 by Dr. David Edward Marcinko MBA MEd CMP™

Comparison with Commonalities

By Staff reporters

***

Filed under: Drugs and Pharma | Tagged: BioNet, corona vaccine, corona virus, Moderna | 1 Comment »

Subscribe MEDICAL EXECUTIVE-POST?

Member Statistics

ME-P Information & Content Channels

Ann Miller RN MHA [Managing Editor]

CERTIFIED MEDICAL PLANNER® program

Most Recent ME-Ps

PodiatryPrep.org

ME-P Free Advertising Consultation

Medical & Surgical e-Consent Forms

iMBA Inc., OFFICES

ME-P Publishing

SEEKING INDUSTRY INFO PARTNERS?

Reader Comments, Quips, Opinions, News & Updates

Start-Up Advice for Businesses, DRs and Entrepreneurs

Up-Trending ME-Ps

Capitalism and Free Enterprise Advocacy

OIG Fraud Warnings

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Calendar

Advertising Info:

Book Offerings:

Dictionary Offerings:

Dr. David Marcinko [Publication List]

Education Online:

Health Dictionary Series Wiki Project

Lower Extremity Medicine & Surgery

Pending NIHCM Grant Applications:

Practice Lists:

Professor Marcinko

Related Blogs:

Speaker's Bureau:

Thought-Leaders:

White Papers: